O
XNCR icon

OrbiMed’s Xencor XNCR Stock Holding History

OrbiMed’s Portfolio XNCR Stock Details XNCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-19,142
Closed -$386K – 134
2023
Q3 		$386K Buy
+19,142
New +$435K 0.01% 124
2018
Q2 		– Sell
-612,500
Closed -$18.4M – 156
2018
Q1 		$18.4M Sell
612,500
-409,600
-40% -$10.7M 0.23% 85
2017
Q4 		$22.4M Buy
1,022,100
+274,856
+37% +$5.96M 0.28% 76
2017
Q3 		$17.1M Hold
747,244
– – 0.16% 90
2017
Q2 		$15.8M Sell
747,244
-92,993
-11% -$2.08M 0.17% 87
2017
Q1 		$20.1M Hold
840,237
– – 0.23% 79
2016
Q4 		$22.1M Buy
840,237
+95,715
+13% +$2.3M 0.28% 67
2016
Q3 		$18.2M Sell
744,522
-126,300
-15% -$2.67M 0.21% 77
2016
Q2 		$16.5M Sell
870,822
-236,200
-21% -$3.24M 0.17% 79
2016
Q1 		$14.9M Hold
1,107,022
– – 0.16% 70
2015
Q4 		$16.2M Sell
1,107,022
-23,000
-2% -$309K 0.15% 76
2015
Q3 		$13.8M Buy
1,130,022
+85,407
+8% +$1.67M 0.14% 82
2015
Q2 		$22.9M Hold
1,044,615
– – 0.19% 81
2015
Q1 		$16M Sell
1,044,615
-1,385
-0.1% -$21.9K 0.14% 86
2014
Q4 		$16.8M Buy
1,046,000
+207,300
+25% +$2.4M 0.16% 81
2014
Q3 		$7.81M Buy
838,700
+37,000
+5% +$374K 0.08% 102
2014
Q2 		$9.32M Hold
801,700
– – 0.11% 88
2014
Q1 		$9.4M Buy
801,700
+99,100
+14% +$1.04M 0.12% 94
2013
Q4 		$6.42M Buy
+702,600
New +$6.03M 0.09% 90

Other funds holding XNCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OrbiMed's XNCR Position: Q4 2023 in Review

OrbiMed sold out of Xencor (XNCR) in Q4 2023, closing a stake of 19,142 shares — an estimated $386K sold.

OrbiMed first reported a position in XNCR in Q4 2013 and held it in 19 quarters. The position peaked at $22.9M in Q2 2015. 195 funds tracked by Wall St. Rank hold XNCR as of Q4 2023.

  • OrbiMed reported no remaining Xencor position as of Q4 2023 after selling out during the quarter.
  • OrbiMed sold 19,142 Xencor shares in Q4 2023, an estimated $386K.
  • OrbiMed first reported a position in Xencor in Q4 2013 and held it in 19 quarters.
  • OrbiMed's Xencor position peaked at $22.9M in Q2 2015.
  • 195 funds tracked by Wall St. Rank held Xencor as of Q4 2023.

Based on OrbiMed's 13F filing for Q4 2023, filed 14 Feb 2024.